GlassScriptPhysician profile
Rosemary Mccabe
NPI 1821295320
$5,752.03
in general payments reported to CMS, 2019-2025
35 companies · $1,214 in 2025
The $1,214 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,002 · 2022: $978 · 2023: $1,772 · 2024: $786 · 2025: $1,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,772.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $890.73 | 2021-2025 | Korlym |
| Abbott Laboratories | $670.15 | 2021-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $660.73 | 2022-2025 | |
| Lilly USA, LLC | $573.84 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $395.73 | 2021-2025 | Sogroya, Ozempic |
| Amgen INC. | $301.81 | 2021-2025 | Evenity, Prolia, Tepezza |
| Astrazeneca Pharmaceuticals LP | $301.30 | 2021-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $277.90 | 2021-2023 | Jardiance |
| Medtronic, INC. | $236.51 | 2021-2024 | Minimed 780g |
| Mannkind Corporation | $175.35 | 2021-2025 | Afrezza |
| Abbvie INC. | $162.28 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $141.14 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Embecta Corp. | $118.69 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Bayer Healthcare Pharmaceuticals INC. | $115.42 | 2023-2025 | |
| Tandem Diabetes Care, INC. | $102.24 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $70.91 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $66.24 | 2021-2025 | Strensiq |
| Ipsen Biopharmaceuticals, INC | $60.33 | 2022-2023 | Somatuline Depot |
| Chiesi USA, INC. | $53.37 | 2025 | Mycapssa |
| Ucb, INC. | $52.96 | 2022 | |
| Recordati_rare_diseases_inc. | $46.36 | 2025 | Isturisa |
| Insulet Corporation | $44.22 | 2023 | Omnipod |
| Becton, Dickinson and Company | $29.12 | 2022 | |
| Sequel Med Tech, LLC | $27.27 | 2025 | Twiist |
| Horizon Therapeutics Plc | $20.92 | 2022 | |
| Beta Bionics, INC. | $19.54 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ionis Pharmaceuticals, INC. | $18.25 | 2025 | Tryngolza |
| Cequr Corporation | $18.11 | 2023 | Cequr Simplicity |
| Pfizer INC. | $15.97 | 2025 | |
| Kyowa Kirin, INC. | $15.60 | 2024 | Crysvita |
| Rhythm Pharmaceuticals, INC. | $15.44 | 2025 | Imcivree |
| Sobi, INC | $14.99 | 2023 | |
| Amphastar Pharmaceuticals, INC. | $13.78 | 2023 | Baqsimi |
| Amarin Pharma, INC. | $13.77 | 2021 | |
| Ibsa Pharma INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosemary Mccabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.